Applied Therapeutics | 8-K: Applied Therapeutics Reports Second Quarter 2024 Financial Results
Applied Therapeutics | 8-K: Current report
Applied Therapeutics | 8-K: Applied Therapeutics Reports First Quarter 2024 Financial Results
Applied Therapeutics | DEFA14A: Others
Applied Therapeutics | DEF 14A: Definitive information statements
Applied Therapeutics | 8-K: Current report
Applied Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Applied Therapeutics | 8-K: Current report
Applied Therapeutics | S-3: Registration statement for specified transactions by certain issuers
Applied Therapeutics | 8-K: Current report
Applied Therapeutics | 8-K: Applied Therapeutics Reports Fourth Quarter and Year-end 2023 Financial Results
Applied Therapeutics | 8-K: Current report
Applied Therapeutics | 8-K: Current report
Applied Therapeutics | 8-K: Current report
Applied Therapeutics | 8-K: Current report
Applied Therapeutics | 8-K: Current report
Applied Therapeutics | 8-K: Current report
Applied Therapeutics | 8-K: Applied Therapeutics Reports Third Quarter 2023 Financial Results
Applied Therapeutics | 8-K: Current report
Applied Therapeutics | 8-K: Current report
No Data
No Data